Multi-function anti-bacterial coating technology KENIFINE™

Unparalleled antibacterial/antifungal effects

You may have concerns about having contact with viruses and bacteria when touching things like:

Train handrail

Smartphone

Elevator button

Note: All images shown are for illustrative purposes only

KENIFINE demonstrates 10 times stronger antibacterial and 50 times stronger antifungal effects than conventional antibacterial technologies.

The KOBELCO Group contributes to the betterment of people's daily lives by making use of KENIFINE technology, which has excellent antibacterial and antiviral properties.

Metallic coating refers to forming a metal thin film on the surface of a metal or non-metal material. The KOBELCO Group has developed a multifunction antibacterial coating technology KENIFINE™ that achieves a higher level of antibacterial and antiviral properties and applied it to coating processes. In addition to the functions mentioned above, it also has antifungal and mold-proof properties. KENIFINE can be effective in the dark as well.

What is KENIFINE™?

COVID-19

It has been confirmed that KENIFINE is effective against the coronavirus similar to the SARS virus, which spread mainly in Hong Kong in 2003. The verification was carried out by the Faculty of Agriculture, Iwate University.

In addition, a third-party organization is currently working to verify the effectiveness of KENIFINE as a suppressor to the novel coronavirus (COVID-19).

The KOBELCO Group will use this technology to ensure people enjoy safe, secure, and prosperous lives during and after the COVID-19 pandemic.

KENIFINE is used in various places such as kitchen sink, kitchen drain, door handle, handrail, air cleaner, air conditioner, nail clipper, ear pick, judo tatami mat, and many more.

KENIFINE™ coated plate for preventing black mold in kitchen drain

KENIFINE™ coated antibacterial bottle opener

T-shirt made with KENIFINE™ printing technology

KENIFINE™ coated door handle and handrails

Judo tatami mat made with KENIFINE™ powder

Where is KENIFINE™ used?

KENIFINE™ was originally developed in 1996, following an outbreak of pathogenic Escherichia coli O157 infections (Sakai-city, Osaka) that shook Japan.